Vpr Protein of Human Immunodeficiency Virus Type 1 Forms Cation-selective Channels in Planar Lipid Bilayers

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1996 Jan 9

PMID 8552585

Citations 40

Authors

S C Piller

G D Ewart

A Premkumar

G B Cox

P W Gage

Affiliations

Soon will be listed here.

Abstract

A small (96-aa) protein, virus protein R (Vpr), of human immunodeficiency virus type 1 contains one hydrophobic segment that could form a membrane-spanning helix. Recombinant Vpr, expressed in Escherichia coli and purified by affinity chromatography, formed ion channels in planar lipid bilayers when it was added to the cis chamber and when the trans chamber was held at a negative potential. The channels were more permeable to Na+ than to Cl- ions and were inhibited when the trans potential was made positive. Similar channel activity was caused by Vpr that had a truncated C terminus, but the potential dependence of channel activity was no longer seen. Antibody raised to a peptide mimicking part of the C terminus of Vpr (AbC) inhibited channel activity when added to the trans chamber but had no effect when added to the cis chamber. Antibody to the N terminus of Vpr (AbN) increased channel activity when added to the cis chamber but had no effect when added to the trans chamber. The effects of potential and antibodies on channel activity are consistent with a model in which the positive C-terminal end of dipolar Vpr is induced to traverse the bilayer membrane when the opposite (trans) side of the membrane is at a negative potential. The C terminus of Vpr would then be available for interaction with AbC in the trans chamber, and the N terminus would be available for interaction with AbN in the cis chamber. The ability of Vpr to form ion channels in vitro suggests that channel formation by Vpr in vivo is possible and may be important in the life cycle of human immunodeficiency virus type 1 and/or may cause changes in cells that contribute to AIDS-related pathologies.

Citing Articles

Cholesterol Modulates the Interaction between HIV-1 Viral Protein R and Membrane.

Liu C, Huang S, Yu T Membranes (Basel). 2021; 11(10).

PMID: 34677550 PMC: 8539443. DOI: 10.3390/membranes11100784.

Pathophysiological Consequences of Calcium-Conducting Viroporins.

Hyser J, Estes M Annu Rev Virol. 2016; 2(1):473-96.

PMID: 26958925 PMC: 6538290. DOI: 10.1146/annurev-virology-100114-054846.

The SARS Coronavirus 3a protein binds calcium in its cytoplasmic domain.

Minakshi R, Padhan K, Rehman S, Hassan M, Ahmad F Virus Res. 2014; 191:180-3.

PMID: 25116391 PMC: 7114474. DOI: 10.1016/j.virusres.2014.08.001.

Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Rivera I, Garcia Y, Gangwani M, Noel Jr R, Maldonado L, Kumar A Virology. 2013; 446(1-2):144-51.

PMID: 24074576 PMC: 3844929. DOI: 10.1016/j.virol.2013.07.027.

T-Cell Signaling in HIV-1 Infection.

Abbas W, Herbein G Open Virol J. 2013; 7:57-71.

PMID: 23986795 PMC: 3751038. DOI: 10.2174/1874357920130621001.

References

Garry R . Potential mechanisms for the cytopathic properties of HIV. AIDS. 1989; 3(11):683-94. DOI: 10.1097/00002030-198911000-00001. View

Wong-Staal F, Chanda P, Ghrayeb J . Human immunodeficiency virus: the eighth gene. AIDS Res Hum Retroviruses. 1987; 3(1):33-9. DOI: 10.1089/aid.1987.3.33. View

Sugrue R, Bahadur G, Zambon M, Douglas A, Hay A . Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 1990; 9(11):3469-76. PMC: 552095. DOI: 10.1002/j.1460-2075.1990.tb07555.x. View

Sugrue R, Hay A . Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology. 1991; 180(2):617-24. PMC: 7131614. DOI: 10.1016/0042-6822(91)90075-m. View

Gras-Masse H, Ameisen J, Boutillon C, Gesquiere J, Vian S, Neyrinck J . A synthetic protein corresponding to the entire vpr gene product from the human immunodeficiency virus HIV-1 is recognized by antibodies from HIV-infected patients. Int J Pept Protein Res. 1990; 36(3):219-26. DOI: 10.1111/j.1399-3011.1990.tb00970.x. View

Lu Y, Clavijo P, Galantino M, Shen Z, Liu W, Tam J . Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system. Mol Immunol. 1991; 28(6):623-30. DOI: 10.1016/0161-5890(91)90131-3. View

Pinto L, Holsinger L, Lamb R . Influenza virus M2 protein has ion channel activity. Cell. 1992; 69(3):517-28. DOI: 10.1016/0092-8674(92)90452-i. View

Westervelt P, Henkel T, Trowbridge D, Orenstein J, Heuser J, Gendelman H . Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J Virol. 1992; 66(6):3925-31. PMC: 241183. DOI: 10.1128/JVI.66.6.3925-3931.1992. View

Duff K, Ashley R . The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology. 1992; 190(1):485-9. DOI: 10.1016/0042-6822(92)91239-q. View

10.

Levy D, Fernandes L, Williams W, Weiner D . Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 1993; 72(4):541-50. DOI: 10.1016/0092-8674(93)90073-y. View

11.

Levy J . Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993; 57(1):183-289. PMC: 372905. DOI: 10.1128/mr.57.1.183-289.1993. View

12.

Lu Y, Spearman P, Ratner L . Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol. 1993; 67(11):6542-50. PMC: 238091. DOI: 10.1128/JVI.67.11.6542-6550.1993. View

13.

Heinzinger N, Bukrinsky M, Haggerty S, Ragland A, Kewalramani V, Lee M . The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A. 1994; 91(15):7311-5. PMC: 44389. DOI: 10.1073/pnas.91.15.7311. View

14.

Levy D, Refaeli Y, MacGregor R, Weiner D . Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1994; 91(23):10873-7. PMC: 45128. DOI: 10.1073/pnas.91.23.10873. View

15.

Tosteson M, Pinto L, Holsinger L, Lamb R . Reconstitution of the influenza virus M2 ion channel in lipid bilayers. J Membr Biol. 1994; 142(1):117-26. DOI: 10.1007/BF00233389. View

16.

Yuan X, Matsuda Z, Matsuda M, Essex M, Lee T . Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses. 1990; 6(11):1265-71. DOI: 10.1089/aid.1990.6.1265. View

17.

Hay A, Wolstenholme A, Skehel J, Smith M . The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985; 4(11):3021-4. PMC: 554613. DOI: 10.1002/j.1460-2075.1985.tb04038.x. View

18.

Cohen E, Terwilliger E, Jalinoos Y, Proulx J, Sodroski J, Haseltine W . Identification of HIV-1 vpr product and function. J Acquir Immune Defic Syndr (1988). 1990; 3(1):11-8. View

19.

Ogawa K, Shibata R, Kiyomasu T, Higuchi I, Kishida Y, Ishimoto A . Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol. 1989; 63(9):4110-4. PMC: 251018. DOI: 10.1128/JVI.63.9.4110-4114.1989. View

20.

Cohen E, Dehni G, Sodroski J, Haseltine W . Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol. 1990; 64(6):3097-9. PMC: 249501. DOI: 10.1128/JVI.64.6.3097-3099.1990. View